Spikevax XBB.1.5 25 micrograms dispersion for injection in pre-filled syringe. COVID-19 mRNA Vaccine
- Licence status
- Active substances
- Andusomeran
- Dosage Form
- Dispersion for injection in pre-filled syringe
- Licence number
- EU/1/20/1507/027-030
- Licence holder
- Moderna Biotech Spain S.L.
Product documents
Licence information
- ATC code
- J07BN01 covid-19, RNA-based vaccine
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Official batch release: In accordance with Article 114 of Directive 2001/83/EC, the official batch release will be undertaken by a state laboratory or a laboratory designated for that purpose.
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 23/04/2025